跳至主要内容
临床试验/NCT03018977
NCT03018977已完成不适用

Protocolized Sedative Weaning Versus Usual Care in Pediatric Critically Ill, Randomized Controlled Trial

Ramathibodi Hospital2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2017年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
incidence of withdrawal symptom

研究概览

简要总结

Sedative and analgesic agents are widely used in the ICU. These agents can provide hypnotic effect, pain alleviation, cooperation, and synchronizing ventilatory support. Prolonged use of the agents can lead to withdrawal symptoms when the drugs are weaned.

Prior study showed the longer duration of sedative drugs, cumulative dose of medications and younger age were the risk factors of withdrawal syndrome. Additional, some study showed the sedation protocol can reduce the incidence of withdrawal syndrome. However, no worldwide standardized sedative weaning protocol including our hospital. The objectives in this study are to establish the sedative weaning protocol and to compare the protocol sedative weaning with the usual care weaning.

详细描述

Sedative and analgesic agents, particularly benzodiazepines and opioids, are widely used in PICU. These agents can provide calmness, hypnotic effect, pain alleviation, cooperation, immobilization and synchronizing ventilatory support.

Prolonged use of the agents can lead to withdrawal symptoms when the drugs are weaned.

Incidence of withdrawal syndrome is about 50%. Withdrawal syndrome can lead to unnecessary and costly diagnostic tests, prolongation of mechanical ventilation and hospital stay, and increasing of suffering. Prior study showed the longer duration of sedative drugs, cumulative dose of medications and younger age were the risk factors of withdrawal syndrome. Additional, some study showed the sedation protocol can reduce the incidence of withdrawal syndrome. However, no worldwide standardized sedative weaning protocol including our hospital.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Month 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 1 mo to 18 yrs, at least 37 week of postmenstrual age
  • Patient who was admitted in PICU or intermediate ward at Ramathibodi hospital
  • use analgesic/sedative drugs (parenteral)≥ 3 days

排除标准

  • Patients in whom level of sedation or withdrawal assessment cannot be scored.
  • Patients transferred from other hospitals in which the patients have already presented of withdrawal symptoms
  • patient/parent refuse this study

研究组 & 干预措施

Sedative weaning protocol

Active Comparator

We create the new sedative weaning protocol and then use the sedative weaning protocol.

干预措施: The sedative weaning protocol group (Other)

Usual Care

Placebo Comparator

no use sedative weaning protocol. Sedative or/and analgesic medications are adjusted base on physician

干预措施: The usual group (Other)

结局指标

主要结局

incidence of withdrawal symptom

时间窗: 72 hour

次要结局

  • sedation related adverse events(7 days)
  • length of PICU stay(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nattachai Anantasit

Assistant Professor

Ramathibodi Hospital

研究点 (2)

Loading locations...

相似试验